| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |